← Home India · nd-india

Alexion to showcase phase III data in hypophosphatasia and hypoparathyroidism at ASBMR 2026 Annual Meeting

Source: pharmabiz · 2026-10-07T00:00:00 UTC

Alexion, AstraZeneca Rare Disease, will deliver 16 presentations, including three oral presentations, across hypophosphatasia (HPP), chronic hypoparathyroidism (HypoPT) and early research at the American Society for

Full article text belongs to the original publisher. Moogle News shows the headline/summary and sends you to the source.

Read full story on publisher site →

Alexion to showcase phase III data in hypophosphatasia and hypoparathyroidism at ASBMR 2026 Annual Meeting

Related in India

GSMA says India must turn mobile scale into growth

Log-hub chief sees AI widening supply chain analysis

xFusion Joins the Linux Foundation to Support Open Source Innovation

Hanspeter Pieth, Delegate of the Board of Directors at Meister 1881, Joins Haelixa Advisory Board to Advance DNA Authentication in Watch and Jewellery

Vodafone Promoters Put NDU on 328 Cr Vodafone Idea Shares

India and Austria Move to Deepen Security and Strategic Cooperation